<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Endocrinol Metab</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Endocrinol. Metab</journal-id>
<journal-id journal-id-type="publisher-id">jcem</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Endocrinology and Metabolism</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-972X</issn>
<issn pub-type="epub">1945-7197</issn>
<publisher>
<publisher-name>Endocrine Society</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30299480</article-id>
<article-id pub-id-type="pmc">6607962</article-id>
<article-id pub-id-type="publisher-id">jcem_201801661</article-id>
<article-id pub-id-type="doi">10.1210/jc.2018-01661</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Research Articles</subject>
<subj-group subj-group-type="category-toc-heading">
<subject>Adrenal</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Characterization of the <italic>CYP11A1</italic> Nonsynonymous Variant p.E314K in Children Presenting With Adrenal Insufficiency</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1175-8269</contrib-id>
<name>
<surname>Kolli</surname>
<given-names>Vipula</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hannah</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Torky</surname>
<given-names>Ahmed</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lao</surname>
<given-names>Qizong</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tatsi</surname>
<given-names>Christina</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mallappa</surname>
<given-names>Ashwini</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3746-0460</contrib-id>
<name>
<surname>Merke</surname>
<given-names>Deborah P</given-names>
</name>
<!--<email>dmerke@nih.gov</email>-->
<xref ref-type="corresp" rid="c1"></xref>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label>National Institutes of Health Clinical Center, Bethesda, Maryland</aff>
<aff id="aff2"><label>2</label>The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland</aff>
<author-notes>
<corresp id="c1"><bold><italic>Correspondence and Reprint Requests:</italic></bold>â€ƒDeborah P. Merke, MD, National Institutes of Health Clinical Center, Building 10, Room 1-2740, 10 Center Drive, Bethesda, Maryland 20892-1932. E-mail: <email>dmerke@nih.gov</email>.</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2018-10-08" pub-type="epub">
<day>08</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>08</day>
<month>10</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="epub"/>. -->
<volume>104</volume>
<issue>2</issue>
<fpage>269</fpage>
<lpage>276</lpage>
<history>
<date date-type="received">
<day>03</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<self-uri xlink:href="jc.2018-01661.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<sec id="s1">
<title>Context</title>
<p>Cholesterol side-chain cleavage enzyme (P450scc), encoded by <italic>CYP11A1,</italic> catalyzes the first step of steroidogenesis. Complete P450scc deficiency leads to primary adrenal insufficiency (PAI) and 46,XY disordered sexual development. Partial impairment can cause variable adrenal and gonadal dysfunction.</p>
</sec>
<sec id="s2">
<title>Objective</title>
<p>Our aim was to evaluate the effects of the <italic>CYP11A1</italic> variant p.E314K, identified in patients with PAI, specifically on P450scc enzyme stability and function.</p>
</sec>
<sec id="s3">
<title>Patients and Methods</title>
<p>We studied four boys from two unrelated families presenting with PAI during childhood (3.6 to 9 years old). All patients were compound heterozygous for c.940G&gt;A (p.E314K), a <italic>CYP11A1</italic> nonsynonymous variant likely to be pathogenic by some but not all <italic>in silico</italic> prediction models, and c.835delA (p.I79Yfs*10), a known pathogenic variant. HEK293T cells were transfected with wild type (WT) and p.E314K mutant vectors, and a cycloheximide chase assay was performed to analyze protein stability. Pregnenolone production was assayed from cells expressing WT and p.E314K-F2 fusion proteins.</p>
</sec>
<sec id="s4">
<title>Results</title>
<p>Two boys experienced spontaneous puberty but then developed evidence of primary gonadal failure at 14 and 18 years old. Two boys had testicular adrenal rest tumor (TART), detected by ultrasound at ages 8.6 and 16 years. Compared with WT, mutant protein synthesis was reduced (<italic>P =</italic> 0.0006) with increased protein turnover, and mutant P450scc half-life was decreased by ~50%. p.E314K mutant P450scc retained 60% of WT enzymatic activity (<italic>P</italic> = 0.007).</p>
</sec>
<sec id="s5">
<title>Conclusions</title>
<p>The <italic>CYP11A1</italic> p.E314K variant impairs P450scc stability and is a possible cause of PAI in childhood. Pathogenic <italic>CYP11A1</italic> variants potentially affect both adrenal and gonadal function, and male patients may develop TART.</p>
</sec>
</abstract>
<abstract abstract-type="teaser">
<p>The <italic>CYP11A1</italic> nonsynonymous variant p.E314K impairs P450scc enzyme stability and function and is associated with adrenal insufficiency in childhood and peripubertal gonadal failure.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>